Right of Shareholders to Call Special Meetings | Interfaith Center on Corporate Responsibility

<div class=”col-lg-9 content-page left-side”>
<section class=”section-a-single-resolutions resolutions-info top-content”>
<div class=”resolutions-contain”>
<div class=”top-content”>
<h4>Resolution Details</h4>
</div>
<div class=”bottom-content”>
<div class=”row-info”>
<strong>Company:</strong>
<p>Medpace Holdings</p>
</div>
<div class=”row-info”>
<strong>Year:</strong>
<p>2026 </p>
</div>
<div class=”row-info”>
<strong>Issue Area:</strong>
<p>Corporate Governance </p>
</div>

<div class=”row-info”>
<strong>Focus Area:</strong>
<p>Shareholder Rights </p>
</div>
<div class=”row-info”>
<strong>Status:</strong>
<p>Filed</p>
</div>

</a>
</div>
</div>
</div>
</section>

<section class=”section-b-single-resolutions content-blocks”>
<div class=”top-content editor-block”>
<div class=”content-block”>
<div class=”main-content”>
<h2>Resolution Text</h2>
<p><strong>RESOLVED</strong>: Shareholders ask our Board of Directors to take the steps necessary to amend the appropriate company governing documents to give the owners of a combined 10% of our outstanding common stock the power to call a special shareholder meeting or the owners of the lowest percentage of shareholders, as governed by state law, the power to call a special shareholder meeting. Such a special shareholder meeting can be an easy to convene online shareholder meeting.</p>
<p><strong>SUPPORTING STATEMENT</strong>:</p>
<p dir=”ltr”>There shall be no poison pill discriminatory rule to require ownership of shares for a specific period of time in order for shares to participate in calling for a special shareholder meeting.</p>
<p dir=”ltr”>There is no concern that allowing 10% of shares to call for a special shareholder meeting is too easy. It is almost unheard of for any special shareholder meeting, called for by shareholders, to ever occur at any company even though a significant number of companies allow 10% of shareholders to call for a special shareholder meeting. <br> <br>In the vast majority of cases or in most cases, once a special meeting is called for by shareholders, the issues behind calling for a special shareholder meeting are quickly resolved.</p>
<p dir=”ltr”>To guard against the Medpace Board of Directors and management becoming complacent Medpace shareholders need the ability to call a special shareholder meeting to help the Board adopt new strategies when Medpace underperforms. If Medpace directors and management know that Medpace shareholders can call a special shareholder meeting they will have more of an incentive to perform better.</p>
<p dir=”ltr”>Now is a good time for this proposal since challenging news reports regarding Medpace emerged in 2025.</p>
<p dir=”ltr”>Medpace experienced weak net book-to-bill ratios in Q4 2024 and Q1 2025, indicating new business awards were not keeping pace with revenue realization. This raised concerns about future revenue growth.<br><br>The Schall Law Firm was investigating Medpace for potential securities law violations, stemming from disclosures in late 2024 about a higher level of cancellations and lower-than-expected book-to-bill ratio.</p>
<p dir=”ltr”>A significant portion (over 80% in the first half of 2025) of Medpace’s revenue comes from small to mid-sized biopharmaceutical companies. These clients face challenges in securing funding from investors, which can lead to project delays or cancellations, posing a material risk to Medpace’s financial performance.</p>
<p dir=”ltr”>News sources and analysts suggested that Medpace’s stock was potentially overvalued, with its price well above analyst-assessed fair value.</p>
<p dir=”ltr”>There were reports of “heavy” insider selling of Medpace stock, including by the CEO and other executives, which can be interpreted negatively as a lack of confidence in long-term prospects.</p>

</div>
</div>
</div>
<div class=”middle-content editor-block”>
<div class=”content-block”>
<div class=”main-content”>

</div>
</div>
</div>

</section>
</div>
<aside class=”col-xl-3 right-side”>
<div class=”column-contain”>

<h3>Lead Filer</h3>
<div class=”views-row”>
<div class=”views-field views-field-nothing”><span class=”field-content”> John Chevedden</span></div><div class=”views-field views-field-title views-field-field-shareholder”><span class=”field-content”>Chevedden Corporate Governance</span></div>
</div>

</div>

</div>
</div>

</div>
</div>
</aside&gt